Abstract
Sera of patients with myocarditis and dilated cardiomyopathy contain stimulatory autoantibodies directed specifically against the beta 1-adrenergic receptor. The binding of the antibodies could be localized to either the first or the second extracellular loop of the beta 1-adrenoceptor. In 73% of the cases investigated the antibodies recognized the second extracellular loop. The agonistic effects of the antibodies were abolished by beta-adrenergic antagonists. Furthermore, the antagonists were able to remove the antibodies from their binding sites.
MeSH terms
-
Adrenergic beta-Antagonists / pharmacology
-
Animals
-
Autoantibodies / analysis*
-
Binding Sites, Antibody / drug effects
-
Binding Sites, Antibody / immunology
-
Cardiomyopathy, Dilated / immunology*
-
Cells, Cultured
-
Epitopes / immunology*
-
Heart Rate / drug effects
-
Heart Rate / physiology
-
Humans
-
Myocardial Contraction / drug effects
-
Myocardial Contraction / physiology
-
Myocarditis / immunology*
-
Myocardium / immunology
-
Rats
-
Rats, Wistar
-
Receptors, Adrenergic, beta / drug effects
-
Receptors, Adrenergic, beta / immunology*
Substances
-
Adrenergic beta-Antagonists
-
Autoantibodies
-
Epitopes
-
Receptors, Adrenergic, beta